Dentsply International ( XRAY) Background: Dentsply designs, develops, manufactures and markets dental consumable products, dental laboratory products and dental specialty products worldwide. The company trades an average of 1.2 million shares per day with a market cap of $6 billion. 52-Week High: $43.71 Beta: 1.37 Price to Book: 2.80 Dentsply reported earnings and the initial market reaction was resoundingly two thumbs down. However, it didn't take long for buyers to step up and acquire shares at a discount. Generally it takes two or three days before volatility settles after a surprise earnings announcement.
Dentsply doesn't have much of a yield at 0.6%, but it certainly beats no dividend. The dividend is on solid footing with less than 25% of profits paid out. On a positive note, the company does have a history of raising the dividend at least once every couple of years for the last 10 years. After reviewing the key numbers inside the earnings report, I believe Dentsply was oversold during the start of trading after releasing the quarterly results. This sets up a buying dip for an entry price of $41.65